Learn more about whether Mercury Systems, Inc. or V2X, Inc. is a better investment based on AAII's A+ Investor grades, which ...

Why the Vertex Price Target Just Got Tweaked The small lift in Vertex Pharmaceuticals' fair value estimate to US$496.16 per ...

Announcements included the MI440X GPU for on-prem enterprise deployments and a longer-term roadmap that includes rack-scale ...

TrinaTracker’s manufacturing facility in Jeddah is now fully operational and has begun supplying Tracker Control Units (TCUs) ...

Trinasolar is expanding its Saudi Arabia presence with major solar projects, partnering with ACWA Power and China Energy ...

Key projects and local manufacturing showcase Trinasolar’s growing role in supporting the kingdom’s Vision 2030 ...

Be quiet!’s new Light base dual chamber cases come in 600 and larger 900 versions with black and white colour options and a ...

March S&P 500 E-Mini futures (ESH26) are down -0.20%, and March Nasdaq 100 E-Mini futures (NQH26) are down -0.32% this ...

TSMC also is investing heavily in U.S. manufacturing, and the company should benefit greatly during this stage of the AI boom ...

The former chief executive of Nexperia, a Dutch chipmaker, said Dutch officials had known for years that the company’s Chinese owner sought to move its technology to China. By Mara Hvistendahl and Joy ...

Some things will remain the same for Vertex five years from now, including its dominance in treating cystic fibrosis (CF). However, the company will likely achieve success in several new markets ...

Robots may not be taking the place of researchers in lab coats running clinical trials anytime soon, but AI is playing an increasingly important role in drug discovery efforts. That’s the message ...